tiprankstipranks
WPD Pharmaceuticals (WPDPD)
OTHER OTC:WPDPD
Holding WPDPD?
Track your performance easily

WPD Pharmaceuticals (WPDPD) Stock Price & Analysis

10 Followers

WPDPD Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

31.61%68.39%
31.61%
Insiders
― Other Institutional Investors
68.39% Public Companies and
Individual Investors

WPDPD FAQ

What was WPD Pharmaceuticals’s price range in the past 12 months?
WPD Pharmaceuticals lowest stock price was $0.03 and its highest was $0.03 in the past 12 months.
    What is WPD Pharmaceuticals’s market cap?
    WPD Pharmaceuticals’s market cap is $608.44K.
      When is WPD Pharmaceuticals’s upcoming earnings report date?
      WPD Pharmaceuticals’s upcoming earnings report date is May 28, 2025 which is in 118 days.
        How were WPD Pharmaceuticals’s earnings last quarter?
        Currently, no data Available
        Is WPD Pharmaceuticals overvalued?
        According to Wall Street analysts WPD Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does WPD Pharmaceuticals pay dividends?
          WPD Pharmaceuticals does not currently pay dividends.
          What is WPD Pharmaceuticals’s EPS estimate?
          WPD Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does WPD Pharmaceuticals have?
          WPD Pharmaceuticals has 4,639,485 shares outstanding.
            What happened to WPD Pharmaceuticals’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of WPD Pharmaceuticals?
            Currently, no hedge funds are holding shares in WPDPD
            ---

            Company Description

            WPD Pharmaceuticals

            WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, research, and development of medicinal products involving biological compounds and small molecules. The company has eight novel drug candidates which are in clinical development and pre-clinical development stage.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Helix BioPharma
            Neo Performance Materials Inc
            Cardiol Therapeutics
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis